Profil
John Alexander Martin is currently Chief Executive Officer & Director at Abcuro, Inc., Chief Executive Officer & Director at Palladio Biosciences, Inc. since 2019, and Chairman at Veralox Therapeutics, Inc. since 2020.
Former positions include Chief Executive Officer at Affectis Pharmaceuticals AG in 2010, Chief Executive Officer at Realm Therapeutics, Inc. from 2015 to 2019, Director at Active With Me, Inc., Associate Director-Diabetes Products at GlaxoSmithKline LLC, Independent Director at Actavia Life Sciences, Inc. from 2016 to 2019, Managing Director at The Sophocles Group LLC from 2009 to 2011, Independent Director at ESSA Pharma, Inc. from 2019 to 2025, Vice President-Business Development at Unigene Laboratories, Inc. from 2010 to 2011, Executive VP-Pharmaceutical Sales & Marketing at Medscape, Inc., Chief Financial & Business Officer at BioXell SpA from 2003 to 2007, Chief Operating Officer at Intercept Pharmaceuticals, Inc. from 2007 to 2009, Senior Vice President-Corporate Development at Moksha8 Pharmaceuticals, Inc. from 2011 to 2015, VP-Global Business Development & Licensing at Novartis Pharmaceuticals Corp.
from 2001 to 2003, and VP-Global Business Development & Licensing at Smithkline Beecham Pharmaceuticals (Canada).
Education includes an undergraduate degree from Cornell University in 1989 and an MBA from Harvard Business School.
Postes actifs de Alex Martin Martin
| Sociétés | Poste | Début |
|---|---|---|
Palladio Biosciences, Inc.
Palladio Biosciences, Inc. BiotechnologyHealth Technology Develops transformative medicines for orphan diseases | Directeur Général | 08/08/2019 |
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery and development services for clinical stage company | Président | 17/09/2020 |
Abcuro, Inc.
Abcuro, Inc. Miscellaneous Commercial ServicesCommercial Services Develops bio therapeutics for treatment of autoimmunity and cancer | Directeur Général | 01/10/2022 |
Anciens postes connus de Alex Martin Martin
| Sociétés | Poste | Fin |
|---|---|---|
| ESSA PHARMA INC. | Directeur/Membre du Conseil | 09/10/2025 |
| ACTAVIA LIFE SCIENCES, INC. | Directeur/Membre du Conseil | 10/07/2019 |
Realm Therapeutics, Inc.
Realm Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of ESSA Pharma, Inc., Realm Therapeutics, Inc. is a company that specializes in precision brain stimulation therapies to address memory loss caused by brain injury and degenerative diseases such as Alzheimer's. The company is based in Radnor, PA. The company's technology, developed at the University of Pennsylvania with DARPA funding, aims to enhance memory, reduce disability, and boost productivity for patients. By utilizing artificial intelligence to analyze brain activity patterns, the company's device delivers personalized stimulation to improve memory performance. The company is currently in the preclinical testing phase and is preparing for FDA approval to conduct clinical trials for patients with memory loss from traumatic brain injury. | Directeur Général | 01/07/2019 |
Moksha8 Pharmaceuticals, Inc.
Moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes medicines | Corporate Officer/Principal | 01/05/2015 |
| UNIGENE LABORATORIES INC | Corporate Officer/Principal | 01/06/2011 |
Formation de Alex Martin Martin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Unigene Laboratories, Inc.
Unigene Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Designs, delivers, manufactures and develops peptide-based therapeutics | Health Technology |
Medscape, Inc.
Medscape, Inc. Data Processing ServicesTechnology Services Operates a web site that provides medical information and interactive medical programs | Technology Services |
BioXell SpA
BioXell SpA BiotechnologyHealth Technology Manufactures drugs for inflammatory diseases | Health Technology |
Intercept Pharmaceuticals, Inc.
Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Moksha8 Pharmaceuticals, Inc.
Moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes medicines | Health Technology |
Active With Me, Inc.
Active With Me, Inc. Miscellaneous Commercial ServicesCommercial Services Provides online resources that seamlessly offer travelers unique, relevant and user-friendly information on activity-based travel | Commercial Services |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Affectis Pharmaceuticals AG
Affectis Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of neurodegenerative and neuroinflammatory diseases | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Smithkline Beecham Pharmaceuticals (Canada) | |
ESSA Pharma, Inc.
ESSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Health Technology |
Realm Therapeutics, Inc.
Realm Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of ESSA Pharma, Inc., Realm Therapeutics, Inc. is a company that specializes in precision brain stimulation therapies to address memory loss caused by brain injury and degenerative diseases such as Alzheimer's. The company is based in Radnor, PA. The company's technology, developed at the University of Pennsylvania with DARPA funding, aims to enhance memory, reduce disability, and boost productivity for patients. By utilizing artificial intelligence to analyze brain activity patterns, the company's device delivers personalized stimulation to improve memory performance. The company is currently in the preclinical testing phase and is preparing for FDA approval to conduct clinical trials for patients with memory loss from traumatic brain injury. | Commercial Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actavia Life Sciences, Inc.
Actavia Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Abcuro, Inc.
Abcuro, Inc. Miscellaneous Commercial ServicesCommercial Services Develops bio therapeutics for treatment of autoimmunity and cancer | Commercial Services |
Palladio Biosciences, Inc.
Palladio Biosciences, Inc. BiotechnologyHealth Technology Develops transformative medicines for orphan diseases | Health Technology |
The Sophocles Group LLC
The Sophocles Group LLC Financial ConglomeratesFinance Provides investment services | Finance |
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery and development services for clinical stage company | Health Technology |
















